Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients

摘要

BackgroundSystemic fungal infection is considered to be an important cause of morbidity and mortality in cancer patients, particularly those with neutropenia. Antifungal drugs are often given prophylactically, or empirically to patients with persistent fever.